Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Etfmg Treatments Testing and Advancements ETF (GERM)

Etfmg Treatments Testing and Advancements ETF (GERM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family ETF Managers Group
  • Assets Under Management 54,519,500
  • Market Capitalization, $K 54,520
  • Shares Outstanding, K 1,850
  • 60-Month Beta -1.66
Trade GERM with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 0.68%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.81 +10.85%
on 10/30/20
30.08 -1.20%
on 11/16/20
+1.07 (+3.74%)
since 10/23/20
3-Month
23.80 +24.87%
on 09/04/20
30.50 -2.56%
on 10/14/20
+1.22 (+4.28%)
since 08/25/20

Most Recent Stories

More News
Moderna ETFs to Shine on Vaccine News as Outbreak Worsens

Positive coronavirus vaccine progress from Moderna (MRNA) has hogged investors' attention.

IBB : 138.95 (+0.51%)
XBI : 126.82 (+0.60%)
BBH : 158.98 (+1.08%)
BTEC : 53.53 (+0.60%)
IDNA : 41.90 (+0.94%)
GERM : 29.72 (+2.10%)
Coronavirus-Themed ETFs in Focus as the Pandemic Worsens

The remainder of 2020 is expected to continue bearing the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.

WFH : 61.03 (+1.95%)
VIRS : 27.87 (+0.58%)
EDUT : 16.96 (+2.23%)
EDOC : 17.77 (-0.17%)
GERM : 29.72 (+2.10%)
Moderna Expects COVID-19 Vaccine Data in November: ETFs to Gain

Positive comment on coronavirus vaccine progress from Moderna's (MRNA) CEO during The Wall Street Journal's annual Tech Live conference has gained investors attention and raised vaccine optimism.

IBB : 138.95 (+0.51%)
XBI : 126.82 (+0.60%)
BBH : 158.98 (+1.08%)
BTEC : 53.53 (+0.60%)
IDNA : 41.90 (+0.94%)
GERM : 29.72 (+2.10%)
5 Coronavirus-Themed ETFs That Can Fight the Pandemic Scares

It feels like the rest of 2020 will continue to bear the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.

WFH : 61.03 (+1.95%)
VIRS : 27.87 (+0.58%)
EDUT : 16.96 (+2.23%)
EDOC : 17.77 (-0.17%)
GERM : 29.72 (+2.10%)
6 Sector ETFs Surviving the Market Rout

Amid the uncertainties, a few sectors have survived last week's turmoil. We have highlighted six of that could be compelling picks for the weeks ahead as long as volatility persists.

AZN : 52.60 (-1.81%)
CNCR : 29.90 (+1.17%)
TAN : 84.25 (+1.47%)
ITB : 56.79 (+0.16%)
RING : 27.96 (+1.56%)
MXI : 77.41 (-0.44%)
GERM : 29.72 (+2.10%)
Will Novavax ETFs Gain on Coronavirus Vaccine Progress?

Investors are closely tracking the progress in the coronavirus vaccine development amid the coronavirus outbreak.

IBB : 138.95 (+0.51%)
XBI : 126.82 (+0.60%)
BBH : 158.98 (+1.08%)
PTH : 143.54 (-0.08%)
DWAS : 69.89 (+0.39%)
GERM : 29.72 (+2.10%)
Direxion Debuts CCON ETF, Expands COVID-19-Themed Product Base

In the current scenario of the rising work-from-home and online shopping trends, online learning, home entertainment, telemedicine and digital health services are slowly becoming the "new normal."

WFH : 61.03 (+1.95%)
VIRS : 27.87 (+0.58%)
EDUT : 16.96 (+2.23%)
EDOC : 17.77 (-0.17%)
GERM : 29.72 (+2.10%)
Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

MRNA : 109.18 (+10.78%)
IBB : 138.95 (+0.51%)
CNCR : 29.90 (+1.17%)
XBI : 126.82 (+0.60%)
BBH : 158.98 (+1.08%)
BTEC : 53.53 (+0.60%)
IDNA : 41.90 (+0.94%)
GERM : 29.72 (+2.10%)
Direxion Debuts CCOC ETF, Expands COVID-19-Themed Product Base

In the current scenario of the rising work-from-home and online shopping trends, online learning, home entertainment, telemedicine and digital health services are slowly becoming the "new normal."

WFH : 61.03 (+1.95%)
VIRS : 27.87 (+0.58%)
EDUT : 16.96 (+2.23%)
EDOC : 17.77 (-0.17%)
GERM : 29.72 (+2.10%)
Moderna ETFs to Shine on U.S. Contracts for Coronavirus Vaccine

Moderna has inked a $1.5-billion coronavirus vaccine supply agreement with the U.S. government.

MRNA : 109.18 (+10.78%)
IBB : 138.95 (+0.51%)
CNCR : 29.90 (+1.17%)
XBI : 126.82 (+0.60%)
BBH : 158.98 (+1.08%)
BTEC : 53.53 (+0.60%)
IDNA : 41.90 (+0.94%)
GERM : 29.72 (+2.10%)

Fund Summary

The ETFMG Treatments Testing and Advancements ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Prime Treatments, Testing and Advancements Index.

See More

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

2nd Resistance Point 30.20
1st Resistance Point 29.96
Last Price 29.72
1st Support Level 29.26
2nd Support Level 28.80

See More

52-Week High 35.15
Fibonacci 61.8% 30.81
Last Price 29.72
Fibonacci 50% 29.48
Fibonacci 38.2% 28.14
52-Week Low 23.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar